Insulet (PODD)
(Delayed Data from NSDQ)
$166.19 USD
+2.02 (1.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $166.26 +0.07 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PODD 166.19 +2.02(1.23%)
Will PODD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PODD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PODD
Insulet (PODD) Outperforms Broader Market: What You Need to Know
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
PODD: What are Zacks experts saying now?
Zacks Private Portfolio Services
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Charles River (CRL) to Report Q1 Earnings: Here's What to Expect
Other News for PODD
Top high growth investment ratio stocks from each sector - GS
ClearBridge Multi Cap Growth Strategy Q1 2024 Portfolio Manager Commentary
ClearBridge Select Strategy Q1 2024 Portfolio Manager Commentary
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
7 Stable Stocks for 50% Returns by Early 2025